Evotec (OTCMKTS:EVTCY) Share Price Passes Below 200-Day Moving Average – Here’s What Happened

Evotec SE (OTCMKTS:EVTCY)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $3.45 and traded as low as $2.40. Evotec shares last traded at $2.41, with a volume of 168,413 shares changing hands.

Evotec Trading Down 4.1%

The stock’s 50-day simple moving average is $3.45 and its two-hundred day simple moving average is $3.45. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.57 and a quick ratio of 2.50. The firm has a market capitalization of $762.81 million, a P/E ratio of 5.63 and a beta of 0.98.

Evotec Company Profile

Evotec SE is a Germany-based biotechnology company specializing in drug discovery alliance and development partnerships. Headquartered in Hamburg, the company collaborates with pharmaceutical and biotechnology firms to deliver integrated solutions across the drug discovery and development continuum. Its offerings span from target identification and validation to lead optimization, preclinical development and manufacturing support.

The company’s platform combines expertise in assay development, high-throughput screening, medicinal chemistry, in vivo pharmacology and safety assessment.